Beta-amyloid (1-42) Antibody (25G13), mAb, Mouse
Beta-amyloid (1-42) Antibody (25G13), mAb, Mouse
| 询价 | |
| V28701 | |
|
|
|
|
|
|
|
|
|
| 询价 | |
| V28701 | |
|
|
|
|
|
|
|
|
|
| Epitope |
|
||||||||||||||||
| Specificity |
|
||||||||||||||||
| Isotype |
IgG2a for mAb 25G13; IgG2b for mAb 6E8 IgG1 for mAb A40 |
| Production |
Cultured in vitro under conditions free from animal-derived components |
| Purification |
Protein A/G affinity column |
| Formulation |
50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 |
| Storage |
For up to three months at 2-8°C or for up to three years at -25°C~-15°C.
Avoid repeated freezing and thawing. |
| Note |
GenScript can customize this product per customer's request including
product size, buffer components, etc. |
|
|||||||||||||
| Target Background |
Beta-amyloid (Aβ or Abeta) are peptides of 36–43 amino acids. They are derived from the amyloid precursor protein (APP) by beta secretase and
gamma secretase in human brain. Beta-amyloid 1-42 and Beta-amyloid 1-
40 are related to Alzheimer's disease (AD). |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are
forbidden.
»
